vTv Therapeutics Announces Larry Altstiel To Serve As Chief Medical Officer

HIGH POINT, N.C.--(BUSINESS WIRE)--vTv Therapeutics Inc. (Nasdaq:VTVT) today announced that Larry Altstiel has joined the company as Chief Medical Officer. Altstiel brings decades of pharmaceutical industry experience and medical expertise to vTv, including serving in senior research and management roles at Pfizer Inc. and Eli Lilly Company. Most recently, Altstiel was Chief Executive Officer of Provectra Biotherapeutics where he led the company's mission in developing gene therapy for neuro-degenerative diseases.

Suggested Articles

A delay to Moderna's phase 3 COVID-19 study is part of a trend of tensions in the biotech’s relationship with the U.S. government, Reuters reported.

GlaxoSmithKline is continuing its strategy of giving out access to its vaccine platform as it adds Medicago to its growing partners list.

Annexon Biosciences and AlloVir are seeking a $100 million IPO apiece in a buoyant market that shows no signs of slowing down.